Harvard is at the center of the Trump administration's higher education pressure campaign — and has emerged as the example of what happens when a university pushes back against the government's demands.
The big picture: By freezing billions in federal funds, derailing international students' futures and levying allegations of antisemitism and discrimination, the administration has squeezed the institution on various fronts as the school becomes the litmus test of how far President Trump will go.
President Trump's Make America Health Again Commission released a highly anticipated report Thursday that gives Americans a clearer sense of HHS Sec. Robert F. Kennedy Jr.'s health agenda.
The big picture: The highly anticipated report hits some of RFK Jr.'s key targets: bad diets, overuse of medicine and corporate influence.
President Trump's Make America Healthy Again Commission blamed factors including bad diets, chemical exposure and unnecessary medication for causing childhood chronic illness in a highly anticipated report released Thursday.
Why it matters: The 68-page document from a panel led by HHS Secretary Robert F. Kennedy Jr. seeks to lay out a unifying theory around what's causing conditions like obesity, autoimmune conditions and behavioral disorders in kids.
As retail pharmacy giants like CVS Health and Walgreens look to find their footing, they could find opportunities customizing services to large employers instead of the mass consumer market.
Why it matters: The industry is shrinking its footprint and pulling back from full-service care delivery. Experts say the biggest players could refashion themselves to become de facto in-house clinics to giant corporations.
With thousands of their brick-and-mortar stores closing and online vendors proliferating, big pharmacy chains like CVS and Walgreens are seeing their reputations slide, according to the annual Axios Harris Poll 100.
Why it matters: The souring consumer sentiment comes as pharmacy giants mount major turnaround plans in the hopes they can overcome slumping in-store sales, overexpansion and backlash from putting more products under lock and key and shortening pharmacy hours.
